Experimental drug given to Trump to treat covid-19 wins FDA clearance

But Regeneron’s antibody treatment is expected to be in short supply.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.